Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort

被引:1
|
作者
Franco, Adriana M. de M. [1 ]
Makita, Lana S. [1 ]
Perrut, Virginia C. [1 ]
Balbi, Gustavo G. M. [2 ]
Barros, Alexandre M. [1 ]
Medina, Flavio M. C. [1 ]
Signorelli, Flavio [3 ,4 ]
机构
[1] Univ Estado Rio de Janeiro UERJ, Hosp Univ Pedro Ernesto HUPE, Ophthalmol Div, Rio de Janeiro, Brazil
[2] Univ Fed Juiz de Fora UFJF, Hosp Univ, Rheumatol Div, Juiz de Fora, Brazil
[3] Univ Estado Rio de Janeiro UERJ, Hosp Univ Pedro Ernesto HUPE, Rheumatol Div, Rio de Janeiro, Brazil
[4] Univ Estadodo Rio de Janeiro, Dept Rheumatol, Blvd 28 de Setembro,77,Serv Reumatol 3 andar,Vila, BR-20551030 Rio de Janeiro, RJ, Brazil
关键词
Antiphospholipid syndrome; antiphospholipid antibodies; thrombosis; ophthalmology; eye; retina; vision; vascular tortuosity; DISEASE; ANTIBODIES; TORTUOSITY; AGREEMENT; DIAGNOSIS; UPDATE;
D O I
10.1177/09612033221143294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To study ophthalmological manifestations in a well-characterized primary antiphospholipid syndrome (PAPS) cohort (APS-Rio) and compare them with a healthy control group. Methods We examined PAPS patients and controls with an extensive ophthalmological evaluation, which included anamnesis, visual acuity, slit-lamp biomicroscopy, binocular indirect ophthalmoscopy, and retinography of the anterior and posterior segments of the eye. PAPS group also underwent angiography exam and optical coherence tomography using spectral domain technology (SD-OCT). Results 98 PAPS patients and 102 controls were included. The most common symptom in PAPS was amaurosis fugax (34.7% vs. 6.9%; p = .001). In the multivariate analyses, Raynaud's phenomenon was associated with amaurosis fugax (OR 3.71, CI:1.33-10.32; p = .012), and livedo correlated with hemianopia (OR 6.96, CI:1.11-43.72, p = .038) and diplopia (OR 3.49, CI:1.02-11.53, p = .047). After ophthalmological evaluation, 84 PAPS patients had ocular involvement (1.0% glaucoma, 94.0% posterior findings, 62.7% anterior findings, and 56.6% both posterior and anterior findings). Vascular tortuosity was more frequent in the PAPS group (63.2% vs. 42.2%; p = .002), as well as peripheral tortuosity (29.6% vs. 7.8%; p < .001). After excluding patients with atherosclerotic risk factors, peripheral vascular tortuosity was still statistically associated with PAPS (35.0 vs. 7.8%, p < .001). Triple positivity was more frequent in PAPS patients with peripheral vascular tortuosity than in those without this ocular finding (34.5% vs. 15.9%, p = .041). Conclusion Vasomotor phenomena are importantly related to ocular symptoms in PAPS. Vascular tortuosity was a frequent finding in PAPS patients. Peripheral vascular tortuosity was associated with triple positivity and might be a biomarker of ischemic microvascular retinopathy due to PAPS.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 5 条
  • [1] Ocular involvement in primary antiphospholipid syndrome -: Ocular involvement in primary APS
    Demirci, FYK
    Küçükkaya, R
    Akarçay, K
    Kir, N
    Atamer, T
    Demirci, H
    Öngör, E
    INTERNATIONAL OPHTHALMOLOGY, 1998, 22 (06) : 323 - 329
  • [2] Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature
    Franco, Adriana M. de M.
    Medina, Flavio Mac Cord
    Balbi, Gustavo Guimaraes Moreira
    Levy, Roger Abramino
    Signorelli, Flavio
    LUPUS, 2020, 29 (12) : 1528 - 1543
  • [3] Ocular involvement in primary antiphospholipid syndrome
    F. Yesim K. Demirci
    Reyhan Küçükkaya
    Koray Akarçay
    Nur Kir
    Tanju Atamer
    Hakan Demirci
    Ercan Öngör
    International Ophthalmology, 1998, 22 : 323 - 329
  • [4] The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
    Radin, Massimo
    Sciascia, Savino
    Erkan, Doruk
    Pengo, Vittorio
    Tektonidou, Maria G.
    Ugarte, Amaia
    Meroni, Pierluigi
    Ji, Lanlan
    Belmont, H. Michael
    Cohen, Hannah
    de Jesus, Guilherme Ramires
    Branch, D. Ware
    Fortin, Paul R.
    Andreoli, Laura
    Petri, Michelle
    Rodriguez, Esther
    Rodriguez-Pinto, Ignasi
    Knight, Jason S.
    Atsumi, Tatsuya
    Willis, Rohan
    Gonzalez, Emilio
    Lopez-Pedrera, Rosario
    Rossi Gandara, Ana Paula
    Gualhardo Vendramini, Margarete Borges
    Banzato, Alessandra
    Sevim, Ecem
    Barbhaiya, Medha
    Efthymiou, Maria
    Mackie, Ian
    Bertolaccini, Maria Laura
    Andrade, Danieli
    Pons-Estel, Guillermo
    Giannakopoulos, Bill
    Krilis, Steve
    de Jesus, Guilherme
    Levy, Roger
    Ugolini-Lopes, Michelle
    Rosa, Renata
    Andrade, Danieli
    Fortin, Paul F.
    Zhang, Zhouli
    Zuily, Stephane
    Wahl, Denis
    Tektonidou, Maria
    Nalli, Cecilia
    Andreoli, Laura
    Tincani, Angela
    Chighizola, Cecilia B.
    Gerosa, Maria
    Meroni, Pierluigi
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (03) : 464 - 468
  • [5] Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS
    Zen, Margherita
    Tonello, Marta
    Carta, Francesco
    Calligaro, Antonia
    Favaro, Maria
    Del Ross, Teresa
    Hulej, Greta
    Rahme, Zahra
    Ruffatti, Amelia
    Doria, Andrea
    RHEUMATOLOGY, 2025,